These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 69003)

  • 21. Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses.
    Ting CC; Bonnard GD
    J Immunol; 1976 May; 116(5):1419-25. PubMed ID: 58034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia.
    Kedar E; Nahas F; Unger E; Weiss DW
    J Natl Cancer Inst; 1978 May; 60(5):1097-106. PubMed ID: 147948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.
    Plata F
    J Exp Med; 1982 Apr; 155(4):1050-62. PubMed ID: 6174669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
    Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
    Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of T cell growth factor on the generation of cytolytic T cells.
    Baker PE; Gillis S; Ferm MM; Smith KA
    J Immunol; 1978 Dec; 121(6):2168-73. PubMed ID: 152789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens.
    Treves AJ; Feldman M; Kaplan HS
    J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.
    Glimcher LH; Longo DL; Green I; Schwartz RH
    J Exp Med; 1981 Nov; 154(5):1652-70. PubMed ID: 6170721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice.
    Ferrantini M; Belardelli F; Locardi C
    J Virol; 1988 Feb; 62(2):600-5. PubMed ID: 2447292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor.
    Plata F; Kalil J; Zilber MT; Fellous M; Lévy D
    J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB; Aoki T; Silverman TN
    Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
    Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sodium periodate modification of lymphocytes on the sensitization and lytic phases of T cell-mediated lympholysis.
    Schmitt-Verhulst A; Shearer GM
    J Immunol; 1976 Apr; 116(4):947-58. PubMed ID: 56407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term culture of tumour-specific cytotoxic T cells.
    Gillis S; Smith KA
    Nature; 1977 Jul; 268(5616):154-6. PubMed ID: 145543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.